CLS B — Clinical Laserthermia Systems AB Share Price
0.000.00%
Last trade - 00:00- SEK60.30m
- SEK34.98m
- SEK18.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | 1.29 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -82.59% | ||
| Return on Equity | -83.19% | ||
| Operating Margin | -288.85% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 1.33 | 2.25 | 6.27 | 8.27 | 18.78 | 37 | 64 | 67.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.
Directors
- Hans von Celsing CHM
- Dan Mogren CEO
- Lars-Erik Eriksson CFO (71)
- Michael Magnani CEX
- Stephan Dymling CTO (61)
- Lotta Ljungberg VPR
- Hoda Tawfik VPR
- Stefan Astrom OTH
- Mats Ekelund OTH
- Ingmar Malm OTH
- Karin Peterson OTH
- Arne Ferstad DRC (69)
- Rolf Kiessling DRC (69)
- Karl-Goran Tranberg DRC (75)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 19th, 2006
- Public Since
- April 16th, 2009
- No. of Employees
- 7
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 20,166,594
- Address
- Scheelev. 2, building 405, LUND, 223 81
- Web
- https://clinicallaser.se/
- Phone
- +46 46152100
- Auditors
- Dillon AB
Upcoming Events for CLS B
Clinical Laserthermia Systems AB Annual Shareholders Meeting
Q2 2025 Clinical Laserthermia Systems AB Earnings Release
Similar to CLS B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Clinical Laserthermia Systems AB share price?
As of Today at 19:59 UTC, shares in Clinical Laserthermia Systems AB are trading at SEK2.99. This share price information is delayed by 15 minutes.
How has the Clinical Laserthermia Systems AB share price performed this year?
Shares in Clinical Laserthermia Systems AB last closed at SEK2.99 and the price had moved by -83.07% over the past 365 days. In terms of relative price strength the Clinical Laserthermia Systems AB share price has underperformed the FTSE Global All Cap Index by -83.49% over the past year.
What are the analyst and broker recommendations for Clinical Laserthermia Systems AB?
The overall consensus recommendation for Clinical Laserthermia Systems AB is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clinical Laserthermia Systems AB dividend yield?
Clinical Laserthermia Systems AB does not currently pay a dividend.
Does Clinical Laserthermia Systems AB pay a dividend?
Clinical Laserthermia Systems AB does not currently pay a dividend.
When does Clinical Laserthermia Systems AB next pay dividends?
Clinical Laserthermia Systems AB does not currently pay a dividend.
How do I buy Clinical Laserthermia Systems AB shares?
To buy shares in Clinical Laserthermia Systems AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clinical Laserthermia Systems AB?
As of the previous close price of SEK2.99, shares in Clinical Laserthermia Systems AB had a market capitalisation of SEK60.30m.
Where are Clinical Laserthermia Systems AB shares listed?
Here are the trading details for Clinical Laserthermia Systems AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CLS B
What kind of share is Clinical Laserthermia Systems AB?
Based on an overall assessment of its quality, value and momentum Clinical Laserthermia Systems AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clinical Laserthermia Systems AB share price forecast for 2025?
The analyst consensus target price for shares in Clinical Laserthermia Systems AB is SEK12.00. That is 301.34% above the last closing price of SEK2.99.
Analysts covering Clinical Laserthermia Systems AB currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Clinical Laserthermia Systems AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clinical Laserthermia Systems AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -45.7%.
As of the last closing price of SEK2.99, shares in Clinical Laserthermia Systems AB were trading -31.36% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clinical Laserthermia Systems AB PE Ratio?
The Clinical Laserthermia Systems AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clinical Laserthermia Systems AB?
Clinical Laserthermia Systems AB's management team is headed by:
- Hans von Celsing - CHM
- Dan Mogren - CEO
- Lars-Erik Eriksson - CFO
- Michael Magnani - CEX
- Stephan Dymling - CTO
- Lotta Ljungberg - VPR
- Hoda Tawfik - VPR
- Stefan Astrom - OTH
- Mats Ekelund - OTH
- Ingmar Malm - OTH
- Karin Peterson - OTH
- Arne Ferstad - DRC
- Rolf Kiessling - DRC
- Karl-Goran Tranberg - DRC